Related Experiment Video
Updated: Aug 16, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Effector domain mutations dissociate p21ras effector function and GTPase-activating protein interaction
J C Stone1, M Colleton, D Bottorff
1Department of Biochemistry, University of Alberta, Edmonton, Canada.
Abstract:
The GTPase activity of p21ras is stimulated by GTPase-activating proteins (GAPs) such as p120GAP and the product of the neurofibromatosis 1 gene, which may negatively regulate p21 function. GAPs are also proposed effectors of ras. We have sought activating substitutions in c-H-ras in the region encoding the effector domain, on the rationale that such mutations would dissociate effector function from negative regulation by GAP. One such activating mutation, Pro-34-->Arg, encodes protein that is substantially bound to GTP in vivo. In vitro, this protein is not stimulated by GAPs, and its binding to p120GAP is grossly impaired. The results support the idea that the p21 structural requirements for effector function and GAP interaction are quite different and suggest that some molecule(s) other than p120GAP serves as the ras effector. In contrast to the results obtained with p120GAP, the Pro-34-->Arg p21 species is effectively coupled to the raf-1 product, as judged from electrophoretic mobility shifts of the Raf-1 phosphoprotein.
Insights
GTPase-activating proteins (GAPs) regulate p21ras function. A specific mutation (Pro-34-->Arg) in c-H-ras impairs GAP binding, suggesting distinct structural requirements for effector function and GAP interaction, and implicating other molecules as ras effectors.
Area of Science:
- Molecular Biology
- Cell Signaling
- Oncogenesis
Background:
- GTPase-activating proteins (GAPs) like p120GAP and neurofibromatosis 1 gene product negatively regulate p21ras GTPase activity.
- GAPs are hypothesized to be ras effectors, mediating downstream signaling pathways.
Purpose of the Study:
- To identify activating substitutions in the c-H-ras effector domain that decouple effector function from GAP-mediated negative regulation.
- To investigate the structural basis for ras effector function and GAP interaction.
Main Methods:
- Site-directed mutagenesis to introduce the Pro-34-->Arg substitution in c-H-ras.
- In vivo GTP-binding assays to assess GTP-bound p21ras levels.
- In vitro assays to evaluate GAP stimulation and p120GAP binding.
- Analysis of p21ras coupling to Raf-1 phosphoprotein.
Main Results:
- The Pro-34-->Arg mutation resulted in a c-H-ras protein substantially bound to GTP in vivo.
- This mutant protein showed impaired binding to p120GAP and was not stimulated by GAPs in vitro.
- The Pro-34-->Arg p21 species effectively coupled to Raf-1, indicated by electrophoretic mobility shifts.
Conclusions:
- The structural requirements for p21ras effector function and GAP interaction are distinct.
- Molecules other than p120GAP likely serve as ras effectors.
- The Pro-34-->Arg mutation provides a tool to study ras signaling independent of GAP regulation.
More Related Videos
Related Concept Videos
GTPases and their Regulation
Large G-proteins, also known...
The Ras Gene
Ras is a superfamily...
GTPases and their Regulation
Large G-proteins, also known...
Amplifying Signals via Enzymatic Cascade
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The JAK-STAT Signaling Pathway

